Our human cardiomyocytes derived from iPS cells are ideal for use in cardiotoxicity testing, drug screening, drug validation as well as metabolism studies and electrophysiology applications.
iPSC Research Spotlight
iPSC and advanced Alzheimer’s Disease research.
Investigating Alzheimer’s Disease progression without looking inside people’s heads:
We spoke with Selina Wray, Professor of Molecular Neuroscience and Alzheimer’s Research UK Senior Research Fellow in the Department of Neurodegenerative Disease at UCL Queen Square Institute of Neurology, London.
Selina explained how developing in vitro models of Alzheimer’s Disease using iPSC’s derived from patient cells will improve translation of therapies to the clinic for the treatment of this neurodegenerative disease.
Featured Research Services
Axol offers a host of custom research services
How can we help you?
Fill in the form and our team of experts will get back to you with answer to your query
Learn how to SCIENCE with our iPSCs, access our validated user protocols
Who we are
Axol is transforming iPSC quality
Axol is a leading provider of product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets. Our custom research capabilities in gene editing, electrophysiology, reprogramming, and differentiation means we can offer customers validated ready-to-use cell lines and a suite of services bolstered by deep scientific expertise and robust functional data – all with shorter lead times